Samantha Khan is a Research Coordinator at the NYU Center for Psychedelic Medicine, where she joined the team in 2021. She coordinates multiple trials investigating MDMA-assisted psychotherapy for the treatment of PTSD. She is also the Research Coordinator for the NYU site of a large multisite trial of psilocybin-assisted therapy for smoking cessation.
Sam has extensive research experience working on social psychology and community health projects in the United States and abroad. A first-generation college graduate, she earned her BA from the University of Rochester before going to the University of Michigan, where she earned her MPH in Health Behavior & Health Education, with a specialization in Gender, Sexuality and Population Health.